Recent News

• 12.11.2025 - Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation
• 12.08.2025 - Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS
• 10.13.2025 - Geron Corporation Announces Executive Leadership Transitions and Appointments
• 09.18.2025 - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 11.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.05.2025 - 8-K Current report
• 11.05.2025 - EX-99.1 EX-99.1
• 10.20.2025 - 3 Initial statement of beneficial ownership of securities
• 10.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.14.2025 - EX-99.1 EX-99.1
• 10.14.2025 - 8-K Current report
• 10.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.08.2025 - 4 Statement of changes in beneficial ownership of securities